NCNA – nucana plc - american depositary shares (US:NASDAQ)
Stock Stats
News
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
NuCana plc (NASDAQ: NCNA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $150.00 to $25.00. They now have an "outperform" rating on the stock.
NuCana plc (NASDAQ: NCNA) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.
NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
Form 6-K NuCana plc For: Nov 12
Form SC 13G/A NuCana plc Filed by: BAILLIE GIFFORD & CO
Form 424B5 NuCana plc
Form 6-K NuCana plc For: Sep 30
Form 6-K NuCana plc For: Sep 26
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.